ASU Regents Professor Charles Arntzen’s research helps advance the production and delivery of a promising treatment for the Ebola virus. For his innovative work — using specially modified tobacco plants that are harvested, ground up into a green liquid, purified and turned into tiny doses of the drug ZMapp — Arntzen is the No. 1 honoree among Fast Company’s “100 Most Creative People in Business.”